NCT00783458View on ClinicalTrials.gov

Single Dose Crossover Study of Patient Preference for Unscented Nasonex® Nasal Spray Versus Scented Flonase® Nasal Spray (Study P04208)

PHASE4CompletedINTERVENTIONAL

Enrollment

100

Participants

Timeline

Start Date

December 1, 2004

Primary Completion Date

January 1, 2005

Study Completion Date

January 1, 2005

Conditions

Allergic Rhinitis

Interventions

DRUG

Mometasone Furoate Nasal Spray

One dose (2 sprays in each nostril) of Mometasone Furoate Nasal Spray

DRUG

fluticasone nasal spray

One dose (2 sprays in each nostril) of fluticasone nasal spray

All Listed Sponsors

lead

Organon and Co

INDUSTRY

NCT00783458 - Single Dose Crossover Study of Patient Preference for Unscented Nasonex® Nasal Spray Versus Scented Flonase® Nasal Spray (Study P04208) | Biotech Hunter | Biotech Hunter